Cefotan
Active Ingredient(s): CefotetanFDA Approved: * December 27, 1985
Pharm Company: * ASTRAZENECA
Category: Antibiotics
Cefotetan is an injectable antibiotic of the cephamycin type for prophylaxis and treatment of bacterial infections. It is often grouped together with second-generation cephalosporins and has a similar antibacterial spectrum, but with additional anti-anaerobe coverage. Cefotetan was developed by Yamanouchi. It is marketed outside Japan by AstraZeneca with the brand names Apatef and Cefotan. Contents 1 Adverse effects 2 Spectrum of bacterial susceptibility 3 References 4 External links A... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.